Website profile

Indian Pharma Post

Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com

  • 186articles · 30d
  • 20+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 90%with images
  • 243avg words
articles per day
Categories
  • Medical 137
  • Health & Wellness 101
  • Economy, Business & Finance 79
  • Health 74
  • Business & Industrial 64
  • Finance & Business 32
  • Science & Technology 21
  • News 14
Bylines

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@pharma_indian
indianpharmapost.com > supply-chain > kaisha-pharma-establishes-italy-hub-to-drive-global-business-development-21781

Kaisha Pharma establishes Italy hub to drive global business development

3+ day, 19+ hour ago   (367+ words) Kaisha Pharma has established Kaisha Pharma International in Italy as its global business development and customer support hub. The move marks latest step in the company’s strategy to build an international pharmaceutical packaging business. Based in Italy, Kaisha Pharma International…...

@pharma_indian
indianpharmapost.com > news > superluminal-medicines-raises-60-million-to-push-obesity-drug-into-clinic-21755

Superluminal Medicines raises $60 million to push obesity drug into clinic

5+ day, 14+ hour ago   (62+ words) Indian Pharma Post Superluminal Medicines raises $60 million to push obesity drug into clinic Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The complexity of compliance The…...

@pharma_indian
indianpharmapost.com > drug-approval > astrazeneca-breast-cancer-drug-wins-us-approval-after-trial-cuts-progression-risk-by-56-21745

AstraZeneca breast cancer drug wins US approval after trial cuts progression risk by 56%

6+ day, 13+ hour ago   (64+ words) The US Food and Drug Administration’s accelerated approval is based on results from the Phase III SERENA-6 trial Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership…...

@pharma_indian
indianpharmapost.com > news > fosun-pharma-announces-hk1-billion-h-share-buyback-21741

Fosun Pharma announces HK$1 billion H-share buyback

6+ day, 20+ hour ago   (289+ words) Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) has announced an H-share repurchase plan of up to HK$1 billion, with the repurchased shares to be either cancelled or held as treasury shares. The company said the programme has come into…...

Google News
indianpharmapost.com > clinical-trials > summits-ivonescimab-delivers-overall-survival-win-against-pembrolizumab-in-phase-iii-lung-cancer-trial-21732

Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial

1+ week, 10+ hour ago   (68+ words) Indian Pharma Post Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The…...

@pharma_indian
indianpharmapost.com > news > gan-lee-signs-up-to-726-million-menarini-deal-for-obesity-drug-in-europe-21733

Gan & Lee signs up to €726 million Menarini deal for obesity drug in Europe

1+ week, 16+ hour ago   (61+ words) The deal gives Gan & Lee a major European partner as the Chinese pharmaceutical company seeks to turn bofanglutide into a global metabolic-health product Priyanka Tewari appointed Head of Marketing at Glenmark Pharma Sonika Natalkar joins Lupin as Deputy General Manager…...

@pharma_indian
indianpharmapost.com > supply-chain > systech-launches-traceiq-for-intelligent-pharma-traceability-21722

Systech launches TraceIQ for intelligent pharma traceability

1+ week, 1+ day ago   (305+ words) The first generation of enterprise traceability platforms was developed primarily to meet serialization mandates, exchange data with trading partners, and satisfy regulatory reporting requirements. Those systems established the compliance foundation the industry relies on today. But as regulations evolve and…...

@pharma_indian
indianpharmapost.com > drug-approval > lupin-gets-us-fda-nod-for-modafinil-tablets-21717

Lupin gets US FDA nod for Modafinil tablets

1+ week, 1+ day ago   (155+ words) Global pharmaceutical major Lupin Limited has received approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP, 100 mg and 200 mg. The approved tablets are bioequivalent to Provigil, the reference listed drug…...

@pharma_indian
indianpharmapost.com > news > astrazeneca-completes-dizal-deal-for-lung-cancer-drug-zegfrovy-21673

AstraZeneca completes Dizal deal for lung cancer drug Zegfrovy

1+ week, 4+ day ago   (60+ words) The deal gives AstraZeneca global control of a drug targeting a particularly aggressive form of lung cancer with significant unmet treatment needs Medtronic to invest $700 million in Hong Kong surgical robotics firm Scan.com raises $220 million to expand US medical…...

@pharma_indian
indianpharmapost.com > clinical-trials > novartis-remibrutinib-delivers-positive-phase-iii-results-in-relapsing-multiple-sclerosis-21671

Novartis’ Remibrutinib delivers positive Phase III results in relapsing multiple sclerosis

1+ week, 4+ day ago   (47+ words) The results point to potential benefits beyond relapse control Medtronic to invest $700 million in Hong Kong surgical robotics firm Scan.com raises $220 million to expand US medical imaging network India Glycols demerges biopharma business into separate entity Dr. Vineet Talwar…...